Genuv
The startup develops CNS drug screening technology that identifies and selects candidate substances to promote the differentiation of neural stem cells into neurons and protect existing neurons. Its platform focuses on discovering high-affinity antibody therapeutics for degenerative brain diseases and cancer, providing patients with access to targeted drug candidates.
- Biotechnology
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops CNS drug screening technology that identifies and selects candidate substances to promote the differentiation of neural stem cells into neurons and protect existing neurons. Its platform focuses on discovering high-affinity antibody therapeutics for degenerative brain diseases and cancer, providing patients with access to targeted drug candidates.